Please check your internet connection and try again.
# Hepamerz (l-Ornithine l-Aspartate)
## Overview
Hepamerz is a combination of the amino acids l-ornithine and l-aspartate. It is used in the management of hyperammonemia, particularly in patients with liver insufficiency. The mechanism involves promoting the detoxification of ammonia in the liver and peripheral tissues.
## Primary Indications
* Treatment of latent and manifest hepatic encephalopathy.
* Adjunctive therapy in patients with liver cirrhosis.
## Adult Dosing
* **Intravenous (IV):** Typically administered as an infusion. Common starting dose is 10 grams (or 5 grams of ornithine and 5 grams of aspartate) per day, infused over 30 minutes to several hours. Higher doses up to 20-30 grams per day have been used in severe cases, divided into multiple infusions. Exact dosing and infusion rates are often guided by clinical response and patient tolerance, and may be based on local protocols.
* **Oral:** Typically 3-6 grams per day, divided into 3 doses.
## Pediatric Dosing
Pediatric dosing is not well-established. Use in children should be based on careful consideration of potential benefits and risks, and guided by institutional protocols or expert consultation. Limited data suggests doses ranging from 100-200 mg/kg/day (as ornithine and aspartate combined) for IV administration.
## Dose Adjustments
No specific dose adjustments are typically required for renal or hepatic impairment, as the drug's mechanism is related to improving liver function and ammonia clearance. However, close monitoring is advised in patients with severe liver disease.
## Contraindications
* Known hypersensitivity to l-ornithine or l-aspartate.
* Severe kidney disease (oliguria or anuria).
## Adverse Effects
Generally well-tolerated.
* **Common:** Nausea, vomiting, abdominal discomfort.
* **Less Common:** Dizziness, headache, allergic reactions (rare).
## Key Drug Interactions
None significant have been well-documented.
## Monitoring
* Monitor for signs and symptoms of hepatic encephalopathy (e.g., confusion, asterixis, altered mental status).
* Monitor electrolytes and renal function periodically.
## Clinical Pearls
* Hepamerz is thought to reduce blood ammonia levels by stimulating the urea cycle in the liver and promoting the conversion of ammonia to glutamine in peripheral tissues.
* The oral form may be used for maintenance therapy or in milder cases.
* Parenteral administration should be done with caution, ensuring adequate hydration.
---
*Disclaimer: This information is intended for healthcare professionals. Always consult the most current prescribing information and institutional guidelines before administering any medication.*
